DrugPatentWatch Database Preview
Patent: 4,994,370
» See Plans and Pricing
Summary for Patent: 4,994,370
| Title: | DNA amplification technique |
| Abstract: | A modification of the polymerase chain reaction (PCR) technique is described. The method allows the amplification of regions of DNA flanking a single region of known sequence, in contrast to standard PCR which requires two regions of known sequence at opposite ends of the fragment to be amplified. Various advantages of the new method are described. |
| Inventor(s): | Silver; Jonathan (Bethesda, MD), Keerikatte; Vijaya R. (Bethesda, MD) |
| Assignee: | The United States of America as represented by the Department of Health (Washington, DC) |
| Application Number: | 07/292,814 |
| Patent Claims: | see list of patent claims |
Details for Patent 4,994,370
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 001 | 1986-06-04 | Start Trial | The United States of America as represented by the Department of Health (Washington, DC) | 2039-02-26 | RX | search | |
| Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 002 | 1986-06-04 | Start Trial | The United States of America as represented by the Department of Health (Washington, DC) | 2039-02-26 | RX | search | |
| Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 003 | 1986-06-04 | Start Trial | The United States of America as represented by the Department of Health (Washington, DC) | 2039-02-26 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
